The Board of Directors of Shukra Pharmaceuticals Ltd, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 5.3855 crore, against ₹1.7751 crore in the corresponding quarter of the previous year (YoY) and ₹3.1879 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹0.0192 crore, against ₹0.0922 crore in the corresponding quarter of the previous year (YoY) and ₹0.0371 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹0.12, against ₹0.59 in the corresponding quarter of the previous year (YoY) and ₹0.24 in previous quarter (QoQ).
Total Income | ₹ 5.3855 crs | ₹3.1879 crs | 68.94% | ₹1.7751 crs | 203.39% |
Net Profit | ₹0.0192 crs | ₹0.0371 crs | -48.25% | ₹0.0922 crs | -79.18 % |
EPS | ₹0.12 | ₹0.24 | -50.00% | ₹0.59 | -79.66% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹8.5734 crore, against ₹3.0235 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹0.0563 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹0.1109 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹0.36 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹0.71 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹8.5734 crs | ₹3.0235 crs | 183.56% |
Net Profit | ₹0.0563 crs | ₹0.1109 crs | -49.23% |
EPS | ₹0.36 | ₹0.71 | -49.30% |
Shares of Shukra Pharmaceuticals Ltd was last trading in BSE at Rs. 51.25 as compared to the previous close of Rs. 53.90. The total number of shares traded during the day was 11 in over 2 trades.
The stock hit an intraday high of Rs. 51.25 and intraday low of 51.25. The net turnover during the day was Rs. 563.00.
Source : Equity Bulls
Keywords
ShukraPharmaceuticals
Q2FY22
H1FY22
ResultUpdate